» Articles » PMID: 20204141

MicroRNA in Situ Hybridization in the Human Entorhinal and Transentorhinal Cortex

Overview
Specialty Neurology
Date 2010 Mar 6
PMID 20204141
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) play key roles in gene expression regulation in both healthy and disease brains. To better understand those roles, it is necessary to characterize the miRNAs that are expressed in particular cell types under a range of conditions. In situ hybridization (ISH) can demonstrate cell- and lamina-specific patterns of miRNA expression that would be lost in tissue-level expression profiling. In the present study, ISH was performed with special focus on the human entorhinal cortex (EC) and transentorhinal cortex (TEC). The TEC is the area of the cerebral cortex that first develops neurofibrillary tangles in Alzheimer's disease (AD). However, the reason for TEC's special vulnerability to AD-type pathology is unknown. MiRNA ISH was performed on three human brains with well-characterized clinical and pathological parameters. Locked nucleic acid ISH probes were used referent to miR-107, miR-124, miR-125b, and miR-320. In order to correlate the ISH data with AD pathology, the ISH staining was compared with near-adjacent slides processed using Thioflavine stains. Not all neurons or cortical lamina stain with equal intensity for individual miRNAs. As with other areas of brain, the TEC and EC have characteristic miRNA expression patterns. MiRNA ISH is among the first methods to show special staining characteristics of cells and laminae of the human TEC.

Citing Articles

Brain cell-specific origin of circulating microRNA biomarkers in experimental temporal lobe epilepsy.

Brindley E, Heiland M, Mooney C, Diviney M, Mamad O, Hill T Front Mol Neurosci. 2023; 16:1230942.

PMID: 37808470 PMC: 10556253. DOI: 10.3389/fnmol.2023.1230942.


Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia.

Piscopo P, Grasso M, Manzini V, Zeni A, Castelluzzo M, Fontana F Front Mol Neurosci. 2023; 16:1127163.

PMID: 37324585 PMC: 10266489. DOI: 10.3389/fnmol.2023.1127163.


Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.

Thangavel R, Bhagavan S, Beladakere Ramaswamy S, Surpur S, Govindarajan R, Kempuraj D J Alzheimers Dis. 2017; 61(2):553-560.

PMID: 29172001 PMC: 5770144. DOI: 10.3233/JAD-170777.


Small RNA Detection by in Situ Hybridization Methods.

Urbanek M, Nawrocka A, Krzyzosiak W Int J Mol Sci. 2015; 16(6):13259-86.

PMID: 26068454 PMC: 4490494. DOI: 10.3390/ijms160613259.


Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.

Zhao Y, Bhattacharjee S, Jones B, Hill J, Dua P, Lukiw W Mol Neurobiol. 2013; 50(1):97-106.

PMID: 24293102 PMC: 4038663. DOI: 10.1007/s12035-013-8595-3.


References
1.
Wilfred B, Wang W, Nelson P . Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab. 2007; 91(3):209-17. PMC: 1978064. DOI: 10.1016/j.ymgme.2007.03.011. View

2.
. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997; 18(4 Suppl):S1-2. View

3.
Nelson P, Wang W, Rajeev B . MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol. 2008; 18(1):130-8. PMC: 2859437. DOI: 10.1111/j.1750-3639.2007.00120.x. View

4.
Makeyev E, Zhang J, Carrasco M, Maniatis T . The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell. 2007; 27(3):435-48. PMC: 3139456. DOI: 10.1016/j.molcel.2007.07.015. View

5.
Saba R, Goodman C, Huzarewich R, Robertson C, Booth S . A miRNA signature of prion induced neurodegeneration. PLoS One. 2008; 3(11):e3652. PMC: 2575400. DOI: 10.1371/journal.pone.0003652. View